Evidence map›Paper›PMID 29236773›Full record

ArticlePloS one2017

First insights into a type II toxin-antitoxin system from the clinical isolate Mycobacterium sp. MHSD3, similar to epsilon/zeta systems.

Daniel Jaén-Luchoro, Francisco Aliaga-Lozano, Rosa Maria Gomila, Margarita Gomila, Francisco Salvà-Serra, Jorge Lalucat, Antoni Bennasar-Figueras

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniel Jaén-LuchoroMicrobiologia, Departament de Biologia, Universitat de les Illes Balears, Palma de Mallorca, Spain.ORCID http://orcid.org/0000-0002-5988-6227
Francisco Aliaga-LozanoMicrobiologia, Departament de Biologia, Universitat de les Illes Balears, Palma de Mallorca, Spain.
Rosa Maria GomilaServeis Cientifico-Tècnics, Universitat de les Illes Balears, Palma de Mallorca, Spain.
Margarita GomilaMicrobiologia, Departament de Biologia, Universitat de les Illes Balears, Palma de Mallorca, Spain.
Francisco Salvà-SerraMicrobiologia, Departament de Biologia, Universitat de les Illes Balears, Palma de Mallorca, Spain.
Jorge LalucatMicrobiologia, Departament de Biologia, Universitat de les Illes Balears, Palma de Mallorca, Spain.
Antoni Bennasar-FiguerasMicrobiologia, Departament de Biologia, Universitat de les Illes Balears, Palma de Mallorca, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A putative type II toxin-antitoxin (TA) system was found in the clinical isolate Mycobacterium sp. MHSD3, a strain closely related to Mycobacterium chelonae. Further analyses of the protein sequences of the two genes revealed the presence of domains related to a TA system. BLAST analyses indicated the presence of closely related proteins in the genomes of other recently published M. chelonae strains. The functionality of both elements of the TA system was demonstrated when expressed in Escherichia coli cells, and the predicted structure of the toxin is very similar to those of well-known zeta-toxins, leading to the definition of a type II TA system similar to epsilon/zeta TA systems in strains that are closely related to M. chelonae.

Indexed as

Bacterial ToxinsMycobacteriumPolymerase Chain ReactionBacterial Toxins

Identifiers

PMID29236773
PMCPMC5728571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.